Objectives
To investigate whether pregnancy and live birth outcomes differ between fallopian tube sperm perfusion and intrauterine insemination in the treatment of non-tubal subfertility.
Search methods
We searched the Menstrual Disorders and Subfertility Group Trials Register (October 2008), MEDLINE (January 1966 to October 2008), and EMBASE (January 1988 to October 2008). Abstracts of the American Society for Reproductive Medicine (1987 Medicine ( to 2008 and European Society for Human Reproduction and Embryology (1987 to 2008) meetings were searched using the same key or text words.
Selection criteria
Only truly randomised controlled studies comparing FSP with IUI were included in this review. Couples with non-tubal subfertility who have been trying to conceive for at least one year were included.
Data collection and analysis
Two review authors independently selected the trials for inclusion based on the quality of the studies.
Main results
Eight studies involving 595 couples were included in the meta-analysis. Only one study reported the live birth rate and there was no evidence of a difference between FSP and IUI (OR 1.2, 95% CI 0.39 to 3.5). There was no evidence of a difference between FSP and IUI for clinical pregnancy per couple (OR 1.2, 95% CI 0.79 to 1.7). A subgroup analysis which included couples with unexplained subfertility only (n = 239) did not report any difference between FSP and IUI (OR 1.6, 95% CI 0.89 to 2.8).
Authors' conclusions
For non-tubal subfertility, the results indicate no clear benefit for FSP over IUI. Therefore the advice offered to subfertile couples regarding the comparative use of FSP versus IUI in the treatment of non-tubal subfertility should reflect this.
P L A I N L A N G U A G E S U M M A R Y

Intrauterine insemination versus fallopian tube sperm perfusion for non-tubal infertility
It remains unclear whether fallopian tube sperm perfusion (FSP) is better than intrauterine insemination (IUI) for non-tubal infertility. Intrauterine insemination (IUI) is an assisted reproduction procedure that places sperm directly into the uterus. Fallopian tube sperm perfusion (FSP) is a similar procedure that places sperm into the woman's fallopian tube, closer to the eggs than IUI, in order to improve the chances of conception. Results of this review of randomised controlled trials indicate that it is unclear whether FSP leads to increased pregnancy rates compared to IUI in couples with non-tubal infertility. The type of catheter used to place sperm in the fallopian tube may be important.
(Synopsis prepared by Menstrual Disorders and Subfertility Review Group)
B A C K G R O U N D
Description of the condition
Controlled ovarian hyperstimulation (COH) together with intrauterine insemination (IUI) is commonly offered to couples with subfertility factors not involving the fallopian tubes. Intrauterine insemination gained its popularity because it is simple, non-invasive, and a cost-effective technique (Hughes 1997). Studies on the dynamics of sperm transport have shown that there is a progressive decline in the numbers of spermatozoa along the length of the female reproductive tract. In normal fallopian tubes a maximum of only 200 spermatozoa are present in the ampulla (Mamas 1996) . Ripps 1994 showed that the number of spermatozoa in the pouch of Douglas was very low after IUI. However, the number of spermatozoa could be significantly increased with utero-tubal flushes. On the other hand, some authors state that there is no correlation between the number of spermatozoa inseminated and subsequent pregnancy rates if at least one to five million spermatozoa are inseminated (Dodson 1991; van Weert 2004). Taking these observations into consideration another simple noninvasive method was introduced, called fallopian tube sperm perfusion.
Description of the intervention
Fallopian tube sperm perfusion (FSP) is based on a pressure injection of 4 ml of sperm suspension while attempting to seal the cervix to prevent semen reflux. This ensures a sperm flushing of the fallopian tubes and an overflow of the inseminate into the pouch of Douglas (Fanchin 1995).
How the intervention might work
FSP was developed to ensure the presence of higher sperm densities in the fallopian tubes at the time of ovulation than provided with standard IUI. However a possible disadvantages of FSP is the large volume of inseminate, which may flush the ova out of the tubes or induce abnormal myosalpingeal contractions resulting in expulsion of the ova from the tube and subsequent failure of fertilisation (Nuojua-Huttunen 1997).
Why it is important to do this review
A number of randomised controlled trials have been published that compare the efficacy of FSP with standard IUI. There were considerable variations in the results. Some of the studies did not have enough power to detect significant differences; therefore, it seemed appropriate to consider pooling the results. The aim of this review was to determine whether outcomes differ between FSP and IUI in improving the probability of conception. As one of the basic requirements for IUI, and subsequently FSP, is the presence of patent tubes we investigated the efficacy of FSP and IUI for the treatment of non-tubal subfertility.
O B J E C T I V E S
To investigate whether live birth rate and rate of ongoing pregnancy outcomes differ between fallopian tube sperm perfusion and intrauterine insemination in the treatment of non-tubal subfertility.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Only truly randomised controlled studies were included in this review. The method of allocation was assessed to determine whether each study was truly randomised or quasi-randomised.
Types of participants
(1) Couples who had been trying to conceive for at least one year.
(2) Male subfertility was defined as semen quality not meeting the criteria for normality as defined by the World Health Organization (WHO) in 1987. Thus, at least one of: sperm concentration < 20 x 10 6 /ml, total motility < 50%, or normal morphology < 50%; < 14% was considered as abnormal when the Kruger criteria were used (Kruger 1993). In 1992 the WHO changed its criteria for sperm morphology from 50% to 30% (WHO 1992). Because many studies were performed before 1992, we used the 1987 definition of normality.
(3) Unexplained subfertility was defined as subfertility for at least one year without any abnormality found at a routine fertility check-up.
(4) The following characteristics of the participants were considered: age of the woman; duration of subfertility; ovulatory status confirmed with a biphasic basal body temperature chart (BBTC), luteal progesterone (P), or sonographic evidence of ovulation; tubal patency; and post-coital testing.
Types of interventions
Trials comparing FSP with IUI were considered with a special focus on:
(1) amount of semen injected;
(2) timing of insemination;
(3) use of a special device for FSP;
(4) method of ovarian stimulation; (5) donor semen, or husband or partner semen.
Types of outcome measures
Studies were considered suitable for inclusion in the meta-analysis if they evaluated outcome measures that were relevant for determining the efficacy of fallopian sperm perfusion compared to intrauterine insemination, determined by:
(1) incidence of live births in both treated and control groups (live birth rate per woman);
(2) incidence of clinical pregnancies in both treated and control groups (pregnancy rate per woman);
(3) incidence of multiple pregnancies, ovarian hyperstimulation syndrome, spontaneous abortions, tubal pregnancies. 
Search methods for identification of studies
Data collection and analysis
AEP Cantineau and MJ Heineman independently selected the trials to be included according to the above-mentioned criteria. Disagreements were resolved through arbitration by BJ Cohlen. Analysis of agreement between the two observers on inclusion of trials was performed using crude percentage agreement. The type of study, participants, interventions, outcome measures, and the quality of all selected studies were extracted and assessed by the same two observers. The following factors were considered for each trial (and labelled: Yes, No, or Not stated).
Trial risk of bias
(1) Method of randomisation: truly randomised, quasi-randomised, or not stated? Where truly randomised was defined as using a centralised randomisation scheme or on-site computer system. Quasi-randomised trials (e.g. alternating record numbers, dates of birth, or odd and even numbers) were excluded. When the randomisation method was not stated, studies were placed in the 'waiting for assessment' category since some studies which claim to be randomised turn out to be not truly randomised (Dias 2006); further information was sought through e-mail and fax. • The number of tubal pregnancies Analyses of agreement, using crude percentage agreement, were performed on the live birth rates, pregnancy rates (PR) per couple and per completed cycle. The raw data were obtained from each study and summarised in a two-by-two table. Odds ratios (ORs) with 95% confidence intervals (CIs) were calculated for each individual trial using the Peto method. An important part of a systematic review is a meta-analysis in which the results of similar randomised trials are pooled. The underlying assumption is that the differences found between these trials are likely to be differences in the extent of treatment effect rather than differences in the direction of treatment effect (Chalmers 1989) . To test the hypothesis that the OR is constant across strata, several statistical methods have been developed. One way of doing this is to look at the graphical display of the 95% CIs of the individual trials (Alderson 2004). When these CIs do not overlap, the differences are likely to be statistically significant, thus the trials are heterogeneous. Statistically significant heterogeneity suggests that the observed differences in results of the individual trials are due to factors other than chance. In this case, one should be cautious about interpreting the estimated overall effect. To test for statistical heterogeneity we used the method of Breslow 1980. They proposed a test that sums up the squared deviations of observed and fitted values, each standardised by its variance. The statistics used follow an approximate Chi 2 distribution with N-1 degrees of freedom, N being the number of trials under study. However, when all trials included are of limited size (with large 95% CIs that are likely to overlap), the power to detect heterogeneity is relatively small and results should be interpreted cautiously. If the trials were statistically homogeneous, we pooled the data for each comparison and calculated the overall combined OR with 95% CI using the Peto method. Although all trials might be statistically homogeneous, differences in clinical parameters are often considerable (clinical heterogeneity). These differences have to be taken into account when interpreting the pooled results. Clinical heterogeneity cannot be avoided because most centres use their own 'materials and methods'. On the other hand when all trials find similar results despite differences in clinical parameters, this strengthens the final conclusions. The Cochrane Handbook for Systematic Reviews of Interventions states: "There is nothing wrong with combining apples and oranges, if one is interested in fruit" (Alderson 2004). In the present review, when trials met the inclusion criteria and performed the same intervention but statistical heterogeneity was detected a random-effects model was used. The differences in participants, interventions, and outcome measures were addressed. When appropriate, subgroup analyses were performed by excluding those trials that used inadequate or completely different 'materials and methods' (for instance, different methods of COH). Besides statistical and clinical heterogeneity, publication bias might also influence the interpretation of the pooled results. Publication bias, the phenomenon by which trials with positive results are more likely to be published (and thus identified) than trials with negative results, applies particularly to smaller trials (Begg 1989) . A way to detect such a bias is to construct a funnel graph, plotting sample size versus effect size (Alderson 2004). In the absence of publication bias the graph is symmetrical.
R E S U L T S Description of studies
See: Characteristics of included studies; Characteristics of excluded studies; Characteristics of studies awaiting classification. In the initial review, 27 studies were found using the adopted search strategy. All these studies were identified as potentially providing data that compared fallopian tube sperm perfusion with intrauterine insemination. Further investigation showed that 10 studies were adequate for inclusion in the review (three studies for sensitivity analysis only). When updating the review, the search was again performed and six additional articles were found; one was eligible for inclusion. We also reviewed the original articles as part of the update and four studies (Gregoriou 1995; Kamel 1999; Papier 1998; Prietl 1999) did not state the exact randomisation method used. Neither did they report concealment of allocation, which made it questionable whether these articles were still suitable for inclusion in the meta-analysis without more detailed information (Dias 2006). Further information was requested using e-mail and fax and it was received. See the Characteristics of excluded studies table. Twenty-one publications in total failed to meet the inclusion criteria because they either did not perform the comparison of interest or did not report a truly randomised trial design with adequate allocation concealment ( (Fanchin 1995; Filer 1996) were not included in the meta-analysis because only data per cycle were reported; or the separate first-cycle data of a cross-over study were not available. One publication (Trout 1999; Trout 1999 extended) was not included in the main metaanalysis but was included in the sensitivity analysis. Trout and co-workers extended the original study with a different group of patients with unexplained subfertility. The extended part of this trial has been treated as a separate trial and is listed as Trout 1999 extended in the tables and graphs. These studies appear in the table 'Characteristics of included studies' and were described in this review. We are still waiting further information on the duration of subfertility of the participants before this study can be included in the main analyses.
Excluded studies
Studies awaiting assessment
See the table Characteristics of studies awaiting classification. Two studies (Kamel 1999; Noci 2007) were placed in the awaiting further assessment category and not included in the updated review since insufficient details about randomisation and concealment of allocation could be obtained from the articles. Attempts were made to contact the authors by e-mail and fax for details that were not reported and for more information about the published data. Eight replies have been received. The additional information from four authors resulted in inclusion of their studies and two studies were excluded (Biacchiardi 2004; Filer 1996a; Gregoriou 1995; Maheshwari 1998; Papier 1998; Prietl 1999).
Participants
Eight studies which reported on 595 women were included in the meta-analysis. The study (Trout 1999) included in the review for the sensitivity analysis only had an additional 269 women. Two studies were not included in the meta-analysis because they did not provide the number of women in each treatment arm (Fanchin 1995) or did not provide first cycle data (Filer 1996a). In all but two studies (El Sadek 1998; Gregoriou 1995), the duration of subfertility was comparable at approximately 3.5 years (range 2.4 to 4.4 years). For the remaining two studies, Gregoriou 1995 reported a mean duration of subfertility of 6.5 and 6.3 years for each group, and the study of El Sadek 1998 reported a mean duration of subfertility of 7.3 and 8.6 years. The age of the women was mentioned in all but two trials (Filer 1996a; Papier 1998), with a mean age (and standard deviation) of 31.2 years (3.7 years). The types of subfertility included were: unexplained subfertility, male subfertility, mild endometriosis, ovarian dysfunction, cervical factor, and light peritubal adhesions. Low sperm count (< 10 6 sperm with progressive motility after migration) was one of the exclusion criteria in four studies (El Sadek 1998; Fanchin 1995; Kahn 1993; Ng 2003) . No study mentioned previous fertility treatment or inclusion of people with secondary subfertility. Eight studies mentioned hysterosalpingography or laparoscopy to check tubal patency as a part of the fertility investigative work-up. Three studies (Fanchin 1995; Filer 1996; Papier 1998) did not give information on the investigative work-up.
Interventions
Four studies (El Sadek 1998; Nuojua-Huttunen 1997; Kahn 1993; Trout 1999) used clomiphene citrate (CC) alone or combined with human menopausal gonadotropin (hMG), followed by one dose of human chorionic gonadotropins (hCG). One study (Ricci 2001) used follicle stimulating hormone (FSH) as u-FSH and one study (Biacchiardi 2004) used r-FSH for ovarian stimulation followed by one dose of hCG. Three studies (Gregoriou 1995; Ng 2003; Papier 1998) stimulated with hMG alone followed by one dose of hCG when the leading follicle was > 18 mm in diameter. One study (Fanchin 1995) used three different stimulation protocols, in which CC, hMG, FSH, and gonadotropin releasing hormone agonist (GnRHa) were combined in different ways. Finally, one study (Filer 1996a) did not mention the type of controlled ovarian stimulation used. The timing of insemination or perfusion was between 34 and 42 hours after hCG in all trials. All studies performed a single insemination for both groups. Two studies (Nuojua-Huttunen 1997; Papier 1998) did not mention the type of injected semen. The remaining studies used semen from the husband. The study of Nuojua-Huttunen described a power calculation that assumed improvement of approximately 15% in favour of FSP over standard IUI as needing 100 couples; 100 couples were included and the trial reported no significant difference. Ng and co-workers stated that 60 (couples) in each arm were needed for a significant difference assuming that the pregnancy rate per cycle would be 25% per cycle for FSP and 10% per cycle for IUI; however, only 30 couples were included in each arm. The study of Trout and coworkers stated that 266 patients needed to be enrolled assuming a pregnancy rate of 15% for IUI and 30% for FSP. They included 268 cycles in total. Finally Ricci and co-workers carried out a power calculation based on previous studies; they used a pregnancy rate per cycle of 8% for IUI and 28% for FSP: 66 cycles per treatment arm would be necessary. Both groups contained 66 cycles and the trial reported no significant difference. All items above are summarised in the 'Quality of included studies table' (Table 1) .
Source of funding
No study reported funding from industry.
Effects of interventions
We identified 27 studies using the adopted search strategy. Overall, eight studies with a total of 595 couples were included in the meta-analysis comparing intrauterine insemination versus fallopian tube sperm perfusion for non-tubal subfertility. An analysis of agreement between the two review authors was performed for the method of randomisation and study design, which resulted in 96% agreement. Arbitration because of disagreement was necessary for one study. . This analysis revealed that couples suffering from unexplained subfertility did not benefit from FSP over IUI (OR 1.6, 95% CI 0.89 to 2.8), Figure 4 . The I 2 statistic for inconsistency was high (67%); therefore, the random-effects model was used and also reporting no evidence of a difference between FSP and IUI (OR 1.5, 95% CI 0.44 to 5.0). 
Multiple pregnancy rate per pregnancy
Five studies included in the meta-analysis reported on multiple pregnancy rates. The prevalence of twins, triplets, and quadruplets was not mentioned separately. There was no evidence of a difference between FSP and IUI (OR 1.6, 95% CI 0.51 to 4.8).
Miscarriage rate per pregnancy
Five studies reported the miscarriage rate per treatment group. The results indicated no evidence of a difference between FSP and IUI (OR 0.51, 95% CI 0.18 to 1.4)). The random-effects model was used to check this result (OR 0.51, 95% CI 0.18 to 1.5) although the test for heterogeneity revealed statistical homogeneity.
Occurrence of ovarian hyperstimulation syndrome (OHSS)
Only one study in the meta-analysis (Fanchin 1995) reported on the occurrence of OHSS. There were no incidences reported in either group.
Ectopic pregnancy rate per pregnancy
Two studies reported the incidence of ectopic pregnancies: Kahn 1993 reported one ectopic pregnancy in the IUI group; and Ricci 2001 reported only one ectopic pregnancy which was in the FSP group. These results gave no evidence of a difference between FSP and IUI (OR 0.37, 95% CI 0.05 to 2.9).
Sensitivity analysis
The inclusion criteria of this review specified that the duration of subfertility had to be at least one year for study participants. In one study the duration of subfertility was not stated (Trout 1999; Trout 1999 extended). A sensitivity analysis was performed leaving out the duration of subfertility as a criterion so that these studies could be included. The pregnancy rate per couple changed from an OR of 1.2 (95% CI 0.79 to 1.7) to an OR of 1.4 (95% CI 0.98 to 1.9) for non-tubal subfertility. The outcome of pregnancy rate per couple changed from an OR of 1.6 (95% CI 0.89 to 2.8) to an OR of 1.9 (95% CI 1.2 to 3.2) for unexplained subfertility. However, the test for heterogeneity showed an I 2 higher than 60% so a random-effects model was used. The results were no longer statistically significant (OR 1.5, 95% CI 0.82 to 2.70), which indicates that the evidence is not very robust.
D I S C U S S I O N
Summary of main results
The aim of this review was to investigate the effectiveness of fallopian tube sperm perfusion (FSP) compared to intrauterine insemination (IUI) with regard to pregnancy rates. The results from the trials included in this review indicate that use of FSP does not lead to higher live birth rates or clinical pregnancy rates than with IUI.
Overall completeness and applicability of evidence
A number of methodological considerations have to be taken into account when interpreting the results as there was significant heterogeneity between the results from the different trials included in the meta-analysis. The types of subfertility differed among the trials. Each trial included unexplained subfertility but four studies also included other types of subfertility, such as mild male subfertility, ovarian dysfunction, cervical factor, light peritubal adhesions, and mild endometriosis (El Sadek 1998; Fanchin 1995; Ng 2003;
Nuojua-Huttunen 1997). Subgroup analysis of trials that included couples with unexplained subfertility only suggested that in these couples FSP might have a small beneficial effect compared to IUI. However a random-effect model, which had to be used because of statistical heterogeneity, did not show a significant treatment effect in favour of FSP. It is known that severe male factor subfertility negatively influences the outcome of IUI (Cohlen 1998). It is unclear what effect other types of subfertility may have on the outcome for IUI or FSP. The question why IUI does not result in the same pregnancy rates for male subfertility remains unanswered.
The mean age of women in the different treatment groups was comparable. In most studies, women aged above 39 years was an exclusion criterion. One trial (Ricci 2001) did not state a maximum age for the women. Most fertility research centres have a maximum age for inclusion due to lower success rates with older women, mainly due to a lower ovarian reserve and oocyte quality in women above 40 years of age (Bukman 2000). The duration of subfertility was at least three years in all included studies. In one study (El Sadek 1998) the duration of subfertility was comparable between the IUI and FSP groups but when compared with the other studies the duration of subfertility was significantly longer. It is known that fertility treatment is less successful with longer duration of subfertility, however the pregnancy rates of El Sadek and co-workers were comparable with the other studies. The method of controlled ovarian hyperstimulation varied among the included studies, which may have introduced clinical heterogeneity. Previous meta-analyses (Cantineau 2007; Crosignani 1996; Hughes 1997) concluded that gonadotropins are more effective than clomiphene citrate for treating subfertile couples in IUI programs. When the ovarian stimulation is more aggressive in one or more of the included studies, pregnancy rate per cycle will rise as well as rates of multiple pregnancies and OHSS. This should be taken into account when comparing study results. However, randomisation was done on the day of insemination, after the ovarian stimulation, which means it is impossible that the ovarian stimulation program influenced any difference between FSP and IUI outcomes. Different methods were also used for sperm preparation, both the swim-up and Percoll gradient techniques. Use of a Percoll gradient might give a higher recovery rate (Cohlen 1998) although a Cochrane review on recovery rates after different semen analysis techniques concluded that no semen preparation technique is superior to another (Boomsma 2007).
Quality of the evidence
Finally, the methodological risk of bias of the included trials was similar. All of the trials were truly randomised. None of the trials used blinding. However, blinding would be methodologically difficult when comparing different insemination techniques and it is not likely that the outcomes are influenced by knowledge of the procedure. An intention-to-treat analysis could not be performed because of insufficient data.
Potential biases in the review process
It is striking that the studies of Biacchiardi and Nuojua-Huttunen reported higher pregnancy rates with IUI after one cycle than other studies after three cycles with IUI (Kahn 1993; Ricci 2001). The power calculations performed for most studies assumed a pregnancy rate of 8% to 15% per cycle for IUI, based on available literature. This is lower than the results of Biacchiardi and Nuojua-Huttunen. The difference might be due to the type of catheter used, however direct evidence for this is lacking. The different types of catheters used for IUI have been compared but no study reported a significantly higher rate of pregnancy with any one of the catheters tested (Fancsovits 2005; Smith 2002; Vermeylen 2006). Publication bias was unlikely as a funnel graph, plotting sample size versus effect size, was symmetrical seeFigure 3.
Agreements and disagreements with other studies or reviews
No other reviews comparing fallopian tube sperm perfusion with intrauterine insemination are known to the authors.
A U T H O R S ' C O N C L U S I O N S
Implications for practice
There is no evidence that FSP results in higher pregnancy rates in couples suffering from non-tubal subfertility than with IUI.
This conclusion is based on eight studies involving a total of 595 couples. As a result no advice can be given, based on the metaanalysis, on the optimal treatment of non-tubal subfertility. We advise, therefore, familiarity with one procedure since knowledge and routine use of one technique is possibly of more importance than the technique itself.
Implications for research
Large, randomised controlled trials should be performed comparing IUI and FSP:
-separately for unexplained subfertility and male subfertility, and using the same optimal stimulation protocol for each treatment group;
-with different types of catheters; and -different types of semen preparation techniques.
When publishing the results, information about randomisation is essential. The number of ongoing pregnancies per couple or live birth rates per couple should be reported as well. Furthermore, the negative aspects of IUI and FSP, such as multiple pregnancies, ectopic pregnancies, and the incidence of ovarian hyperstimulation syndrome should be more carefully documented.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Biacchiardi 2004
Methods Randomisation: blocked computer-generated sequence of numbers 
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion Allahbadia 1998 Randomisation method was not stated, and the groups were not equal (369 in IUI group and 20 in FSP group), which makes adequate randomisation impossible. The author did not reply to our request for further information. Duration of subfertility was not stated Arroyo Vieyra 1995 Randomisation method was not stated, and the groups were not equal (95 cycles with IUI and 36 cycles with FSP), which makes adequate randomisation improbable. The author did not reply to our request for further information
Ciftci 1998
The trial was quasi-randomised. The duration of subfertility was not stated. The author gave additional information regarding data after the first cycle. However this data was only pregnancies per cycle. Moreover there were no data available on the duration of subfertility Desai 1998 Randomisation method was not stated, but the groups were not equal (369 in IUI group and 20 in FSP group), which makes adequate randomisation improbable. The author did not reply to our request for further information. The duration of subfertility was not stated 
D A T A A N D A N A L Y S E S
Comparison 1. Intrauterine insemination versus fallopian tube sperm perfusion
Analysis 1.7. Comparison 1 Intrauterine insemination versus fallopian tube sperm perfusion, Outcome 7
Sensitivity analysis: pregnancy rate per couple for non tubal subfertility (any duration of infertility).
Review: Intra-uterine insemination versus fallopian tube sperm perfusion for non-tubal infertility 
Analysis 1.8. Comparison 1 Intrauterine insemination versus fallopian tube sperm perfusion, Outcome 8 Sensitivity analysis: pregnancy rate per couple for unexplained subfertility (any duration of infertility).
Review: Intra-uterine insemination versus fallopian tube sperm perfusion for non-tubal infertility Heterogeneity: Chi 2 = 11.99, df = 4 (P = 0.02); I 2 =67%
Test for overall effect: Z = 2.54 (P = 0.011) 0.02 0.1 1 10 50 
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A D D I T I O N A L T A B L E S
